MEDU-13. FUNCTIONAL CRISPR-CAS9 SCREEN IDENTIFIES DRUGGABLE DEPENDENCIES IN MYC-DRIVEN MEDULLOBLASTOMA

Myc-driven Medulloblastoma remains a major therapeutic challenge due to frequent metastasis and a poor 5-year survival rate. Myc overexpression results in transcriptional dysregulation, proliferation, and survival of malignant cells. However direct inhibition of Myc remains an obstacle to therapeuti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Veo, Bethany, Fosmire, Susan, Wang, Dong, Madhavan, Krishna, Pierce, Angela, Venkataraman, Sujatha, Vibhakar, Rajeev
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Medulloblastoma
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477310/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.172
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak